EP PerMed Logo

EP PerMed Newsletter 22 | 13 October 2026

Dear subscribers,

Welcome back after the summer break! We are pleased to bring you a new edition of the EP PerMed newsletter, with fresh updates from across the personalised medicine community. Among the highlights are the pre-announcement of the EP PerMed Joint Transnational Call 2027 on Cell and Gene Therapy for Personalised Medicine, our new report on public awareness and perceptions of personalised medicine, and an invitation to join the EP PerMed Stakeholder Forum.

This edition also features new funding opportunities, recent insights on implementing personalised medicine in the Nordic countries, and a selection of upcoming events and networking opportunities. We hope you enjoy catching up on the latest developments and look forward to an active autumn for the EP PerMed community.

The EP PerMed Consortium

 

EP PerMed News

13 October 2026

image

Pre-announcement: EP PerMed JTC2027

EP PerMed is launching the Joint Transnational Call 2027 for Cell and Gene Therapy for Personalised Medicine (CGT4PM2027). The call aims to fund projects focusing on the development and validation of innovative and novel cell and gene therapies for personalised medicine. The full call text will be published on 4 November 2026.

Read more

17 September 2026

image

New EP PerMed Report Explores Public Awareness and Perceptions of Personalised Medicine

EP PerMed has published a new report presenting the first results of its multilingual survey on public awareness, perceptions, expectations and concerns regarding Personalised Medicine (PM). The findings provide a baseline for understanding how people perceive personalised medicine and highlight important priorities for communication, engagement, trust and equitable access.

Read more

08 September 2026

image

Join the EP PerMed Stakeholder Forum to Move Personalised Medicine Forward

The EP PerMed Stakeholder Forum brings together researchers, clinicians, companies, patients, regulatory stakeholders, and other key players in personalised medicine (PM) on a single platform to accelerate the translation of research findings into clinical practice and marketable applications.

Read more

27 - 29 April 2027

image

Joint EP PerMed & ICPerMed Conference in Berlin

EP PerMed and ICPerMed will jointly organise a conference in Berlin, Germany, from 27 to 29 April 2027. The event will focus on collaborations to accelerate personalised medicine innovations and solutions into healthcare. Networking and exchange between research, innovation and healthcare are at the heart of the conference, which brings together the personalised medicine community from Europe and beyond.

Read more

23 July 2026

image

Round Table Report Highlights Pathways to Implement Personalised Medicine in Nordic Countries

EP PerMed has published the summary report of its third round table, which examined challenges, successful approaches and industry perspectives on the implementation of personalised medicine in the Nordic countries. The round table took place on 18 May 2026 in Copenhagen, Denmark, bringing together representatives from companies, healthcare innovation organisations, public funding bodies and national personalised medicine infrastructures.

Read more

Other PM-related News

12 October 2026

image

JA PCM Invites Stakeholders to Shape a Public-Private Partnership for Personalised Cancer Medicine

The Joint Action on Personalised Cancer Medicine (JA PCM) is inviting patients, citizens and public stakeholders to two online consultations on 26 and 27 October 2026. The discussions will contribute to the development of a possible public-private partnership (PPP) for personalised cancer medicine that could continue beyond the Joint Action.

Read more

16 September 2026

image

New Regional Funding Opportunities for Digital Health

Two new funding opportunities of interest to the personalised medicine community have recently been launched or announced through the UNITE and SYSTEMEU initiatives. The calls support the development and implementation of digital health solutions across Europe.

Read more

14 September 2026

image

Health-NCP-Net 3.0 Publishes Guide to Health Funding Opportunities Across Horizon Europe

Health-NCP-Net 3.0 (HNN 3.0) has published ‘Health research and innovation funding opportunities across Horizon Europe with deadlines from September to December 2026’. The guide brings together health-related opportunities from the 2026-2027 Horizon Europe Work Programmes across all three pillars, extending beyond Cluster 1: Health.

Read more

See all news

Events

21 October 2026 - Cyber Resilient Healthcare

27 October 2026 - ERA4Health Synergies Workshop 2026: Bridging Knowledge and Action: Advancing Policy Uptake through Synergies

26 October 2026 - Towards a Public-Private-Partnership in Personalised Cancer Medicine: Patients' and Citizens' Perspective

27 October 2026 - Towards a Public-Private-Partnership in Personalised Cancer Medicine: Public Stakeholders' Perspective

27 - 30 October 2026 - EP PerMed Implementation School on Personalised Medicine - A Sex- and Gender-Sensitive Approach

02 - 03 November 2026 - Network Meeting on Brain Tumours

16 November 2026 - TEHDAS2 Final Conference

24 - 25 November 2026 - HNN3.0 | Brokerage Event on Horizon Europe Cluster 1 2027 Calls

26 November 2026 - Horizon Europe Info Days - Cluster 1

03 December 2026 - EP PerMed JTC2027 Information Day

04 December 2026 - 1+ Million Genomes Initiative – High-level Event

18 - 21 January 2027 - PRISM Networking Event: Digital Twins for Personalised Radiotherapy through Integrated Simulation and Modelling

27 - 29 April 2027 - Joint EP PerMed & ICPerMed Conference in Berlin

See all events

EUROPEAN PARTNERSHIP

EP PerMed has received funding from the European Union's Horizon Europe research and innovation programme under grant agreement No 101137129.

Imprint

EP PerMed is coordinated by:
DLR Projektträger
Health | Innovations for Disease Control
Heinrich-Konen-Straße 1
53227 Bonn, Germany

phone +49 228 3821-1144
e-mail: eppermed@dlr.de

www.eppermed.eu | LinkedIn | www.DLR-PT.de

For information about data protection, please see our Privacy Policy

You receive this email because you have registered for the EP PerMed Newsletter. If you want to unsubscribe please click here.